Targeted Perfusion Based Haemodynamic Management in Critically Ill Patients Using Urethral Perfusion

NARecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

December 1, 2024

Conditions

Critically Ill

Interventions

DRUG

250 ML NaCl 4.5 MG/ML Injection

Bolus 250 ml crystalloid. Usually 0.9% saline or compound sodium lactate solution at discretion of attending clinician

Trial Locations (1)

RECRUITING

King's College Hospital, London

All Listed Sponsors

lead

King's College Hospital NHS Trust

OTHER